Barinthus Biotherapeutics promotes Graham Griffiths to COO effective Sept 1, 2024

Barinthus Biotherapeutics plc.

Graham Griffiths promoted from Chief Business Officer to COO, effective Sept 1, 2024.
Salary increased to £336,144 in connection with the promotion.
Griffiths joined Barinthus in Oct 2017; previously COO and co-founder of Agalimmune Ltd.
No related party transactions or family relationships with directors or officers.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Graham Griffiths

Chief Operating Officer

BRNS · Barinthus Biotherapeutics plc.

Effective: 2024-09-01
Filed: September 5, 2024, 7:59 PM ET

Effective September 1, 2024 (the “Effective Date”), Barinthus Biotherapeutics plc (the “Company”) has promoted Graham Griffiths, the Company’s Chief Business Officer, to Chief Operating Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Graham Griffiths changed role as Chief Operating Officer at Barinthus Biotherapeutics plc..

Action: promoted
Role: Chief Operating Officer

Exact text from the filing

Effective September 1, 2024 (the “Effective Date”), Barinthus Biotherapeutics plc (the “Company”) has promoted Graham Griffiths, the Company’s Chief Business Officer, to Chief Operating Officer.

View on SEC.gov

Barinthus Biotherapeutics plc. filing history →

Source: SEC EDGAR

accession 0001104659-24-097364

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.